There were no significant differences between control and case groups in terms of age, median time since diagnosis, CD4 count at the beginning of follow-up, CD4 count at the commencement of the study, percentage of patients infected with hepatitis C virus, percentage of patients presenting with non-AIDS defining events during the follow-up period, and number of HIV-RNA blips during the follow-up period. Here, CD4 is linked to AIDS.